You would think that 70 years after the high altitude experiments at Dachau, that researchers (especially German ones) would be more aware of the ethics of human research. And what about the Journal of American Medical Association publishing this ethical abomination?
In a study published today in the Journal of the American Medical Association, German researchers report exposing human study subjects to high altitude (almost 15,000 feet) to see that would happen to them. Saving that these subjects were volunteers, the Nazi’s did similar work at Dachau.
The new research violates the Nuremberg Code at least as follows:
- The experiment was very dangerous and could have resulted in cerebral or pulmonary edema (i.e., see first sentence in media release below). Harm, albeit reversible, was in fact experienced by the study subjects.
- The experiment is not of any scientific value as it involved only 14 human guinea pigs.
- The experiment was non-therapeutic in nature and offered no medical benefit to the study subjects.
- The potential results (apparently limited to satisfying morbid scientific curiosity) did not justify the risks.
The researchers claimed to have obtained informed consent from the study subjects. But even if the subjects did sign a consent form, it would be interesting to see what the consent form disclosed.
The media release is below.
Research finds retinal vessel leakage during high altitude exposure
“Exposure to high altitude can cause acute mountain sickness (AMS) and, in severe cases, cerebral or pulmonary edema. Capillary leakage has been hypothesized to play a role in the pathogenesis of AMS, although the mechanism of altitude-related illnesses remains largely unknown,” writes Gabriel Willmann, M.D., of the University of Tubingen, Germany, and colleagues. “Vessel leakage in the retinal periphery has not been investigated. Our objective was to assess retinal vessel integrity at high altitude using fluorescein angiography.”
As reported in a Researcher Letter, the study included 14 healthy, unacclimatized volunteers (7 male and 7 female participants, average age, 35 years) who were studied at baseline (1,119 feet), after ascent to 14,957 feet within 24 hours, and more than 14 days after return by fluorescein angiography. Photographs were independently graded in random order by 4 ophthalmologists for presence and location of leakage.
Retinal abnormalities were not noted at baseline in any of the participants. At high altitude, marked bilateral leakage of peripheral retinal vessels was observed in 7 of 14 participants (50 percent). All findings completely reversed after descent. “Retinal capillary leakage should be considered a part of the spectrum of high-altitude retinopathy,” the authors write.